이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Effects of Ketogenic Diet on Alcohol Intoxication

2026년 8월 3일 업데이트: University of Pennsylvania
The research study is being conducted to better understand the effects of ketosis on brain functioning and the acute effects of alcohol. Participants will be asked to undergo ~4 weeks of ketogenic diet intervention. The study involves three lab visits: Lab 1 before starting the diet, Lab 2 after about 2 weeks after starting the diet, and Lab 3 after being on the diet for 4 weeks. All of the labs will include an alcohol tolerance test, and blood draws. Lab 1 and Lab 3 will also include an Magnetic resonance imaging scan. Due to scheduling, study procedures at 2 and 4 weeks may occur +/- 3 days. Magnetic resonance imaging (MRI) of the brain will measure levels of nicotinamide adenine dinucleotide (NAD) (a coenzyme that is important for energy metabolism), lactate (a metabolite produced during energy metabolism), and neurotransmitters glutamate and GABA. Alcohol tolerance will be tested using a dose of alcohol (approximately 4-5 alcohol beverages) to will elevate breath alcohol levels to approximately 0.08% to measure the acute effects of alcohol. Blood samples will be collected to measure varying metabolites.

연구 개요

상태

모병

정황

개입 / 치료

상세 설명

Consent and Screening Session (approximately 4 hours).

The following will occur at this visit. The visit may be completed on more than one day at the CSA following signed consent:

  • Participants will be asked to show a legal photo ID and then undergo a breathalyzer test to ensure that they are able to make a well-reasoned decision about whether or not to participate in the study. The breath alcohol level must be 0.000% to sign the consent form.
  • Participants will be asked to provide demographic information, including current address to be registered as a patient at the University of Pennsylvania.
  • A clinician will perform a medical history and physical examination. Trained study staff will draw a total of approximately 3 tablespoons (44 mL) of blood for standard laboratory tests and genetic analysis.
  • A urine sample is required for routine urinalysis, drug screen, ketone levels, and a pregnancy test for woman who are able to become pregnant.
  • Study personnel will measure vital signs (blood pressure and pulse), weight, and height.
  • Study personnel will complete a brief psychiatric interview record alcohol and cigarette use over the past 90 days.
  • Participants must complete a screening evaluation form in advance of the MRI exam for the presence of medical implants or other foreign bodies that could pose an injury when undergoing MRI.

Staff will call participants within 5 business days of completing the screening visit to confirm whether study eligibility and schedule the rest of the study visits.

Dietary Intervention (4 weeks each)

Participants will be asked to adhere to a 4-weeks ketogenic diet. Depending on scheduling availability, in may include an additional 3 days. All meals will be provided by a commercial meal service (Factor75) and will be delivered to participants residence weekly. Participants are asked to just eat the food provided for the 4-weeks of the study. Compliance to the dietary intervention will be assessed daily with a urine ketone levels test that will be performed each morning. A picture of the test will be sent by text or email daily. Blood ketone levels will be checked on the days of the lab visits. Each week a staff member will call participants to check on their health and wellbeing, make sure they are receiving study meals and record the amounts of each meal consumed during the week. Staff will also ask questions about mood and record alcohol use for each week.

Study lab visits lab 1 and 3 (week 4; approximately 8 hours. each) Staff will call the night before to reminder participants not to eat or drink anything except water after midnight the day before and on the day of the study visit. The study will provide breakfast and lunch. Staff will review the current list medications and vitamins provided at the screening visit, and will inquire about any changes.

Lyft ride service will be used to bring participants to Stellar Chance Laboratories (440 Curie Blvd.).

On the day of the study lab visits, the following will occur:

  • A light meal will be provided, participants must have a breath alcohol level of 0.000% to continue, finger stick for blood glucose level, and vital signs. Participants will be asked about recent use of drugs, alcohol, and nicotine. Staff will collect a urine sample to conduct a drug screen, urine ketone level, and a pregnancy test (for woman able to become pregnant).
  • A brain 7-Tesla MRI scan (~1.5 hour) will be performed. An MRI is a type of scan that uses radio waves to take detailed pictures of the body. Participants will be asked to lie on an MRI table where the technologist will place a receiver on the head. A blanket can be provided for comfort and earplugs since the MRI makes noises while it is scanning. Participants will still be able to hear some sound to ensure communication with the technologist and can follow any direction given throughout the MRI scan. The technologist will slowly slide participants into the MRI magnet where radio waves will be transmitted into the head.

Participants will be asked to:

  • fill out an MRI safety form.
  • remove any metal from the body.
  • Staff will provide earplugs for the noise from the MRI scanner, and position participants on the imaging table with their head in the scanner, held comfortably in a special head holder.
  • Participants will be instructed not to move the head and to lie as still as possible during the scan (~ 90 minutes). There will be several scans, during which staff will obtain a structure image of the brain, NAD (a cofactor involved in energy metabolism), lactate (a byproduct of energy metabolism) and neurotransmitter GABA and glutamate.

After the scan Lyft will be used to travel to 3535 Market St. for the reminder of the laboratory visit.

  • A blood sample will be collected, and lunch will be provided
  • A dose of alcohol calculated to elevate breath alcohol concentration to approximately 0.08% will be provided. Staff will measure alcohol intoxication prior to and at pre-specified times following alcohol administration using the following measurements: breath alcohol concentration, motor (groove pegboard task) and cognitive (go-no-go task) tests, and questionnaires. Study personnel will ask about side effects that may have occurred throughout the laboratory procedures.
  • At the end of the laboratory procedures, participants will be provided a snack and staff will measure blood glucose and ketone levels. Participants will return home by Lyft.

Study lab visit 2 (week 2; approximately 5 hours.) Staff will call the day before to reminder participants not to drink alcohol after 10pm the night before and set up a Lyft ride to 3535 Market St. Participants are asked to eat breakfast at home before coming to the visit. Staff will review the current list medications and vitamins provided at the last study visit, and record any changes.

On the day of the study lab visits, the following will occur:

  • Staff will record participants breath alcohol level (must be 0.000% to continue), finger stick for blood glucose level, and vital signs. Staff will ask about recent use of drugs, alcohol, and nicotine. Participants will be asked to provide a urine sample to conduct a drug screen, urine ketone level, and a pregnancy test (for woman able to become pregnant).
  • Blood sample will be collected, and lunch will be provided
  • A dose of alcohol calculated to elevate breath alcohol concentration to approximately 0.08% will be provided. Staff will measure alcohol intoxication prior to and at pre-specified times following alcohol administration using the following measurements: breath alcohol concentration, motor (groove pegboard task) and cognitive (go-no-go task) tests, and questionnaires. Study personnel will ask about side effects throughout the laboratory procedures.
  • At the end of the laboratory procedures, a snack will be provided and staff will measure blood glucose and ketone levels. Participants will return home by Lyft.

연구 유형

중재적

등록 (추정된)

20

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 연락처 백업

연구 장소

    • Pennsylvania
      • Philadelphia, Pennsylvania, 미국, 19104
        • 모병
        • Center for Studies of Addiction
        • 부수사관:
          • Cindy Li, Ph.D.
        • 연락하다:
        • 수석 연구원:
          • Corinde Wiers, Ph.D

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 성인

건강한 자원 봉사자를 받아들입니다

예

설명

Inclusion Criteria:

  1. Age 21 years to 50 years old.
  2. Willingness to provide signed, informed consent and commit to completing study procedures. Reported on at least one day in the month prior to consent of consuming 2 or more standard alcohol drinks on a single day.

Exclusion Criteria:

  1. Unwilling or unable to refrain from use, within 24 hours of the alcohol lab procedures, psychoactive medications or medication that may affect study results.
  2. Current DSM-5 diagnosis of any major psychiatric disorder (other than nicotine use disorders, or marijuana use disorders) as identified by clinical examination or structured interview that could interfere with study participation or make it hazardous for the subject.
  3. Currently taking medication(s) that could interfere with study participation or make it hazardous for the subject to participate. (e.g. anticholinergics; antipsychotics; lithium; psychotropic drugs not otherwise specified)
  4. Positive urine drug screen, positive for all substances but marijuana at screening or study visits (may be repeated once and if the result is negative on repeat, it is not exclusionary).
  5. A current, clinically significant physical disease or abnormality on the basis of medical history, or routine laboratory evaluation that can impact brain function, the use of a ketone supplement, administration of ketogenic diet, or the use of alcohol (e.g., epilepsy, diabetes, irritable bowel syndrome, Crohn's disease, liver disease, kidney disease, kidney stones, chronic metabolic acidosis or a cardiomyopathy as determined by history and clinical exam).
  6. Currently suffering from or has a history of stroke and/or stroke related spasticity.
  7. Head trauma with loss of consciousness for more than 30 minutes or associated with skull fracture, inter-cranial bleeding or abnormal MRI (self-report, medical history).
  8. Weight greater than 225lbs (Need to cap amount of alcohol given based on weight to individuals).
  9. Females who are pregnant or breast-feeding
  10. Contraindication to MRI, including presence of ferromagnetic objects, claustrophobia or fear of enclosed, medical conditions that prevent subjects from lying comfortably flat on his/ her back for up to 2 hrs.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 기초 과학
  • 할당: 해당 없음
  • 중재 모델: 단일 그룹 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Ketogenic diet
4 week ketogenic diet intervention
4 week ketogenic diet

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Effects of ketogenic diet on cerebral levels of glutamate.
기간: 4 weeks
Glutamate levels will be measures with magnetic resonance imaging prior to and after the 4 week ketogenic diet.
4 weeks

2차 결과 측정

결과 측정
측정값 설명
기간
Effects of ketogenic diet on Breath alcohol levels
기간: 4 hours
Breath alcohol levels will be measures during the alcohol tolerance lab prior to and after 4 weeks ketogenic diet.
4 hours

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

협력자

수사관

  • 수석 연구원: Corinde Wiers, Ph.D., University of Pennsylvania
  • 연구 책임자: Henry Kranzler, MD, University of Pennsylvania

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2026년 5월 14일

기본 완료 (추정된)

2027년 8월 31일

연구 완료 (추정된)

2030년 5월 1일

연구 등록 날짜

최초 제출

2026년 5월 15일

QC 기준을 충족하는 최초 제출

2026년 5월 15일

처음 게시됨 (실제)

2026년 5월 22일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 8월 4일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 8월 3일

마지막으로 확인됨

2026년 8월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • 23-0733
  • K99AA031746 (미국 NIH 보조금/계약)

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .